Background Primary prevention strategies for cardiovascular disease (CVD) conventionally rely on 10-year risk estimates of ...

A 3D model accurately mimicking the blood-brain barrier (BBB) in a laboratory environment has been successfully developed by ...

THOMASVILLE- According to the World Health Organization, Cardiovascular Disease (CVD) is one of the leading causes of death ...

ALEXIS SIMPKINS NEUROLOGY Associate Professor, Neurology Cedars-Sinai Dr. Alexis Simpkins is a top clinician scientist who ...

The International Stroke Conference is the world's premier meeting dedicated to the science and treatment of cerebrovascular disease and brain health. Brain aneurysms often result in subarachnoid ...

Orphan drugs offer critical treatment options for rare diseases, improving quality of life for underserved patients and ...

Among individuals with obesity and cardiovascular disease, those with large weight gain or loss had a higher risk for ...

Background: Agalsidase beta is used to treat Fabry disease (FD); however, data on cardiac and cerebrovascular outcomes with agalsidase beta treatment come from studies with limited numbers of patients ...

A new study has found older-looking brains in adults with sickle cell disease, helping to explain the cognitive challenges experienced by such individuals. A brain image from a healthy individual ...

A CT angiogram of the brain at Aster Whitefield Hospital in June last year showed a “puff of smoke” appearance - a hallmark sign of Moyamoya disease, a rare cerebrovascular disorder often ...

SINGAPORE: Researchers at the National University of Singapore (NUS) have made significant strides in understanding the complex interplay between cerebrovascular disease (CeVD) and Alzheimer’s ...

The current human tissue-based study provides convincing evidence correlating hippocampal expressions of RNA guanine-rich G-quadruplexes with aging and with Alzheimer's Disease presence and severity.